USPTO serial 76327945
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
New York, NY
New York, NY
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stacey Hallerman
STACEY HALLERMAN PFIZER INC150 E 42ND ST 6TH FLNEW YORK, NY 10017-5612UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations for the prevention and treatment of cardiovascular disorders | ABANDONED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 14, 2003 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Feb 10, 2003 | PAPER RECEIVED | — | |
| Nov 15, 2002 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Oct 8, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 18, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 19, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 9, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 6, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 31, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 28, 2001 | DOCK | ASSIGNED TO EXAMINER | — |